Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Efficacy of Dexmedetomidine Added to Patient Controlled Epidural Analgesia for Patients Undergoing Major Abdominal Cancer Surgery

NCT03453424 is registered in ClinicalTrials.gov with South Egypt Cancer Institute as lead sponsor.

NCT NCT03453424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Efficacy of Dexmedetomidine Added to Patient Controlled Epidural Analgesia for Patients Undergoing Major Abdominal Cancer Surgery
Lead sponsor
South Egypt Cancer Institute
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2017
Completion date
May 30, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, abdominal pain